Deorphaning pyrrolopyrazines as potent multi-target antimalarial agents

Area of Science:

• Medicinal Chemistry
• Computational Biology
• Parasitology

Background:

• Malaria remains a significant global health challenge, necessitating the development of novel antimalarial drugs.
• Pyrrolopyrazines represent a promising class of compounds with potential antimalarial properties.

Purpose of the Study:

• To discover and characterize novel pyrrolopyrazines as potent antimalarial agents.
• To elucidate the molecular targets and mode of action of these compounds using computational methods.

Main Methods:

• Synthesis and in vitro testing of pyrrolopyrazine derivatives against Plasmodium falciparum and Plasmodium berghei.
• Ligand- and structure-based computational modeling for macromolecular target prediction.
• Bioinformatics analysis to identify potential parasite targets and off-targets.

Main Results:

• Several pyrrolopyrazine compounds demonstrated potent antimalarial activity with EC50 values in the low nanomolar range.
• Negligible cytotoxicity was observed against HepG2 cells, indicating a favorable safety profile.
• Computational predictions identified IspD, an enzyme in the non-mevalonate pathway, and essential Plasmodium falciparum kinases as likely targets.
• The study validated computational approaches for predicting drug targets and understanding polypharmacology.

Conclusions:

• Pyrrolopyrazines are a promising scaffold for developing new antimalarial drugs.
• Integrated computational and experimental approaches are effective for target identification and drug discovery.
• The identified targets provide new avenues for antimalarial drug development and understanding resistance mechanisms.